0 Comentários
0 Compartilhamentos
486 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Cancer Immunotherapy Market Size, Share, Trends, Key Drivers, Demand and Opportunity AnalysisCancer Immunotherapy Market Segmentation, By Product Type (Checkpoint Inhibitors, Monoclonal Antibodies, Vaccines, Cell Therapies, Immunomodulators and Oncolytic Virus), Application (Lung Cancer, Breast Cancer, Melanoma, Multiple Myeloma, Prostate Cancer, Ovarian Cancer, Cervical Cancer, Stomach Cancer, Colorectal Cancer, Head & Neck Cancer, and Others), End User (Hospitals, Oncology...0 Comentários 0 Compartilhamentos 339 Visualizações 0 Anterior
-
Lung Cancer Therapeutics Market: Driving Innovations in Targeted and Immunotherapy SolutionsThe lung cancer therapeutics market is witnessing rapid advancements in targeted therapies, immuno-oncology, and personalized medicine. Increasing prevalence of lung cancer and growing investments in biotechnology are fueling significant market growth. Get a full overview of market dynamics, forecasts, and trends. Download the complete Display Market...0 Comentários 0 Compartilhamentos 757 Visualizações 0 Anterior
-
Therapeutic Categories: Analyzing the Americas Cancer Immunotherapy Market Segment by TypeThe Americas Cancer Immunotherapy Market segment is defined by its diverse therapeutic modalities, each serving distinct clinical needs and contributing uniquely to market revenue. The dominant segment is Immune Checkpoint Inhibitors (ICIs), including PD-1, PD-L1, and CTLA-4 blockers. This segment commands the largest revenue share due to their widespread use as a first-line therapy...0 Comentários 0 Compartilhamentos 554 Visualizações 0 Anterior
-
Cancer Treatment Market Opportunities: Growth, Share, Value, Size, and Scope By 2029Global Executive Summary Cancer Treatment Market: Size, Share, and Forecast The global cancer treatment market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 12.1% in the forecast period of 2022 to 2029 and is expected to reach USD 524,921.84 million by 2029 from USD 215,900.00 million...0 Comentários 0 Compartilhamentos 488 Visualizações 0 Anterior
-
Glioblastoma Treatment Market Overview, Growth Analysis, Trends and Forecast By 2029"Executive Summary Glioblastoma Treatment Market: Share, Size & Strategic Insights The expected CAGR of global glioblastoma treatment market is tend to be around 9.30% in the forecast period of 2022 to 2029. The market was valued at USD 2.34 billion in 2021, and it would grow upto USD 4.77 billion by 2029. For an excellent outcome of Glioblastoma Treatment Market report,...0 Comentários 0 Compartilhamentos 916 Visualizações 0 Anterior
-
Lentiviral Vector Market Overview, Growth Analysis, Trends and Forecast By 2032Lentiviral Vector Market: Enabling Breakthroughs in Gene Therapy During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 11.90%, primarily driven by the rising demand for gene and cell therapies, especially in the treatment of cancer and genetic disorders. The Lentiviral Vector Market is emerging as a critical enabler of the biotechnology and pharmaceutical...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Pet Cancer Therapeutics Market Trends: Growth, Share, Value, Size, and Analysis By 2032Regional Overview of Executive Summary Pet Cancer Therapeutics Market by Size and Share The global pet cancer therapeutics market size was valued at USD 309.69 Million in 2024 and is expected to reach USD 621.62 Million by 2032, at a CAGR of 9.10% during the forecast period. Pet Cancer Therapeutics Market analysis gives a clear idea on various segments...0 Comentários 0 Compartilhamentos 621 Visualizações 0 Anterior
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek
